INTEGRA Biosciences AG
 

« Previous article
INTEGRA adds to Reag...

10th June 2013  Content supplied by: 

Reproducible Isolation of High Quality RNA


INTEGRA has released a new video demonstrating a solid phase extraction (SPE) microplate method for reproducible, high throughput isolation of high-quality DNA-free total RNA.

Large scale gene expression screening projects require reliable high-throughput methods to isolate high quality RNA from a large number of samples. To meet this need, a growing number of commercial 96-well format RNA isolation kits are now available. Typically such kits are compatible with commonly used 96-well plate vacuum manifolds enabling the extraction (isolation) procedure to be accelerated.

The video shows how researchers use a VIAFLO 384 handheld electronic pipette in conjunction with vacuum manifold, 96-well solid phase extraction (SPE) microplate and RNA isolation kit to reproducibly extract high quality total RNA from cultured cells and bacteria.

The VIAFLO 384 is a handheld 384-channel electronic pipette that offers all the benefits of increased sample throughput as well as lower sample and reagent use without the expense of having to invest in a robotic liquid handling system. Designed to be used just like a standard handheld pipette the VIAFLO 384 requires no special skills or training to operate it. The VIAFLO 384 features INTEGRA's popular Touch Wheel™ pipette user interface enabling simple and fast programming of a wide range of pipetting modes including repeat dispense, serial dilute and mixing routines.

To watch the RNA isolation video please visit www.youtube.com. For further information on the VIAFLO 384 please contact INTEGRA in Europe / Asia on telephone +41-81-286-9530 / email info@integra-biosciences.com or in North / South America on telephone +1-603-578-5800 / email US@integra-biosciences.com


Share on:

Tags:


Date Published: 10th June 2013


View full company details




INTEGRA Biosciences AG

Address:

CH-7205 Zizers

Switzerland

Tel: +[41] 81 286 95 30

Email Supplier

View full company details


Related news from INTEGRA Biosciences AG